TaraESeeryMD

PubMed

• 87 citations
  Identification and characterization of RET fusions in advanced colorectal cancer.
  Anne-France Le Rolle, Samuel J. Klempner, Christopher R. Garrett, Tara Elisabeth Seery, Eric M. Sanford
  Oncotarget. 2015-10-06
• 85 citations
  A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105
  Alexander Drilon, Siqing Fu, Manish R. Patel, Marwan Fakih, Ding Wang
  Cancer Discovery. 2019-03-01
• 194 citations
  Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma...
  Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip, Sunil R. Hingorani, Jill Lacy
  Journal of Clinical Oncology. 2019-02-28

Journal Articles

• Pancreatic Neuroendocrine Tumors Therapy  
  T. Seery, A. Choudhry, A Eapen, Y Cheng, J Pancreas, 1/1/2017
• Current Options for Third Line Treatment of Metastatic Colorectal Cancer  
  A. Grothey, J. Marshall, T. Seery, Clinical Advances in Hematology and Oncology, 1/1/2016
• Durable Response using Regorafenib in An Elderly Patient with metastatic Colorectal Cancer: Case Report  
  R. Tang, T. Kain, J Herman, T. Seery, Cancer Management and Research, 1/1/2015
• Role of Surgical Resection Among Chemotherapy-Treated Colorectal Cancer Patients with Stage IV Disease: A survival Analysis  
  Tsang, W. Ziogas, A., Lin, B., Seery, T.E., Karnes, W., Stamos, M., Zell, J., Journal of Gastrointestinal Surgery, 1/1/2014
• MRI following treatment of advanced HCC with sorafenib  
  Joon-II Choi, David Imagawa, Priya Bhosale, Puneet Bhargava, Temel Tirkes, Tara E Seery, Chandana Lall, Clinical and Molecular Hepatology, 1/1/2014
• Composite liver tumors: A Radiologic-Pathologic Correlation  
  M. Nayyar, D. Imagawa, T. Tirkes, A. Demirjian, R. Houshyar, K. Sandrasegaran, C. Nangia, T. Seery, P. Bhargava, J. Choi, C. Lall, Clinical and Molecular Hepatology, 1/1/2014
• Mortality Risk After Preoperative versus Postoperative Chemotherapy and Radiotherapy in Lymph Node Positive Rectal Cancer  
  Seery, T.E., Ziogas, A., Lin, B., Pan, CG, Stamos, M., Zell, J., Journal of Gastrointestinal Surgery, 1/1/2013
• A Phase II Study of MK-2206, an Allosteric Inhibitor of AKT as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer, a SWOG Cooperative Group ...  
  R.K. Ramanathan, S.L McDonough, H.F.Kennecke, S. Iqbal, J.C. Baranda, T. E. Seery, H.J. Lim, A. F. Hezel. G. M. Vaccaro, C. C. Blanke, Cancer, 1/30/2015
• Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S115 Study Randomized Clinica...  
  V. Chung, S. McDonough, PA Philip, A. Wang-Gillam, L Hui, MA Tejani, T Seery, IA Dy, T. Al Baghdadi, AE Hendifar, LA Doyle, AM Lowy, KA Guthrie, CD Blanke, HS Hochster, JAMA Oncol, 1/15/2016
• Halo 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients with Untreated, Metastatic Pancreatic Duc...  
  S. Hingorani, L. Zheng, A. Bullock, T. Seery, W. Harris, D. Sigal, F. Braiteh, P Ritch, M. zalupski, N Bahary, P Oberstein, A. Wang-Gillam, W. Wu, D. Chondros, P, Jian..., Journal of Clinical Oncology, 1/1./2018
• Join now to see all

Abstracts/Posters

• Clinical trial screening of CDKN2A genomic alterations in patients with pancreatic cancer and hepatobiliary cancers requires greater precision than somatic sequencing ...
  C. Vaske, C. Gardner, T. Seery, C. Szeto, S. Reddy, ASCO GI, 1/1/2019
• NANT Cancer Vaccine an orchestration of immunogenic cell death by overcoming immune suppression and activating NK and T cell therapy in patients with third line or gr...
  Tara Seery, Mira Kistler, Arvind Shinde, Anand Annamalai, Leonard Sender, Frank Jones, Omid Jafari, John Lee, Patrick Soon-Shiong, SITC, 1/1/2018
• A phase IB/II randomized study of mFOLFIRINOX(mFFOX) + pegylated recombinant human hyaluronidase (PEGPH20) versus mFFOX alone in patients with good performance status ...
  R. Ramanthan, S. McDonough, P. Philip, S. Hingorani, J. Lacy, J. Kortmansky, J. Thumar, E. Chiorean, A. Shields, D. Behl, P. Mehan, R. Gaur, T. Seery, K Guthrie, H. Ho..., ASCO GI, 1/1/2018
• Three-fold overestimation of tumor mutation burden using 248 gene panel versus whole exome
  A. Nguyen, C. Garner, S. Reddy, J. Sanborn, S. Benz, T. Seery, S. Rabizadeh, ASCO Annual Meeting, 1/1/2018
• Phase 1 dose escalating study of hypoxia-activating agent tirapazamine in combination with trans-arterial embolization in patients with intermediate stage hepatocellul...
  Nadine Abi-Jaoudeh, Dayantha Fernando, Kari Nelson, Hanna Javan, Renata Guzman, Tara Seery, Po-Chin Liang, Pei-Jer Chen, Jen-I Hwang, David Imagawa, EASL, 1/1/2017
• Global Phase 3, Randomized, Double Blind, Placebo Controlled Study Evaluating PEGylated Recombinant Human Hyaluronidase PH20 (PEGPH20) Plus nab-Paclitaxel and Gemcitab...
  Lei Zheng, Andrew Hendifar, Michele Reni, William Harris, Michael Ducreux, Andrea Bullock, Pippa Corrie, Tara Seery, Dimitrios Chondros, Eric Van Custem, AACR, 1/1/2017
• Interim results of a randomized phase 2 study of PEGPH20 added to nab-paclitaxel/gemcitabine in patients with stage IV previously untreated pancreatic cancer
  Sunil R. Hingorani, William P. Harris, Tara Seery, Lei Zheng, Darren Sigal, Andrew Hendifar, Fadi Braiteh, Mark Zalupski, Ari Baron, Nathan Bahary, Andrea Wang-Gillam,..., GI ASCO, 1/1/2016
• Insertion site inflammation, CLABSI, and Readmissions due to Outpatient Central Lines
  Hiroki Saito, Mohamad Alsharif, Bardia Bahadori, Li Chen, BA, Tara E. Seery, Jennifer Yim, Linda Dickey, Susan S. Huang, Shruti K. Gohil, SHEA (Society for Healthcare Epidemiologists of America), 1/1/2016
• Global Phase 3, Randomized Double Blind Placebo Controlled Study Evaluating PEGylated Recombinant Human Hyaluronidase PH20 Plus nab-Paclitaxel and Gemcitabine in Patie...
  E. Van Custem, A. E. Hendifar, M. Feni, W.P. Harris, M. Ducreux, A. Bullock, P. Corrie, V. Heinemann, T. Seery, D. Chondros, L. Zheng, ESMO, 1/1/2016
• Axitinib Safety and Pharmacokinetics in Child Pugh A and Child Pugh B Patients with Advanced Hepatocellular Cancer
  Yoon-Koo Kang, Tara E. Seery, Mina Kato, Debasis Chakrabarti, Olga Valota, Ying Chen, Jie Tang, Yazdi K. Pithavala, Masatoshi Kudo, AACR Annual Meeting, 1/1/2015
• Pilot Study Comparing the Pharmacokinetics of Sorafenib in the Asian-American Population vs Non-Asian Population in the Treatment of Hepatocellular Carcinoma
  Mark Hanna MD, Zhobin Moghadamyeghaneh MD, Tara E Seery MD, Aram Demirjian, David Imagawa MD, ASCO Annual Meeting, 1/1/2015
• A retrospective, single-institution experience of resected ampullary adenocarcincoma: predictors of clinical outcome
  Ronald Tang MD, Michael Sgroi MD, David Imagawa MD, Tara Elisabeth Seery MD, ASCO Annual Meeting, 1/1/2015
• High Response Rate and PFS with PEG20 added to Nab-Paclitaxel/Gemcitabine in Stage IV Previously Untreated Pancreatic Cancer Patients with High-HA Tumors: Interim Resu...
  A. Hendifar MD, S. Hingorani MD, W. Harris MD, T. Seery MD, D. Sigal MD, W. Wu, S. Dychter, P. Jiang, World GI Congress, 1/1/2015
• A Phase II Study of MK2206, an Allosteric Inhibitor of AKT as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction (GEJ) Cancer, a SWOG Cooperative G...
  R. Ramanathan, S. McDonough, H. Kennecke, S. Iqubal, J. Baranda, T.E. Seery, H. Lim, A. Hezel, G. Vaccaro, C. Blanke, ASCO, 1/1/2014
• Role of surgical resection among chemotherapy-treated patients with colorectal cancer stage IV disease: A survival analysis
  B. S. Lin, A. Ziogas, T. E. Seery, M. J. Stamos, J. A. Zell, J Clin Oncol, 1/1/2011
• Mortality risk after preoperative versus postoperative chemotherapy and radiotherapy in lymph node�positive rectal cancer
  T. E. Seery, A. Ziogas, B. S. Lin, C. G. Pan, M. J. Stamos, J. A. Zell, Clin Oncol, 1/1/2011
• The Prevalence of Second Malignancies and Autoimmune Diseases in Patients with Lymphoproliferative Disorders
  Seery, T.E., Sycheva T., and Oo ,T., Blood, 1/1/2006
• Management of Unresectable Hepatocellular Carcinoma
  Seery T, UC Irvine 5th Annual Gastroenterology and Hepatology Symposium, 1/23/2013
• Join now to see all

Lectures

• Innate and adaptive immunotherapy: An orchestration of immunogenic cell death by overcoming immune suppression and activating NK and T cell therapy in patients with th... 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
• Discussion on the state of Pancreatic Cancer 
  1/1/2018
• Cutting Edge Management of Pancreatic Cancers 
  1/1/2018
• Randomized Phase 2 Study of PEGPH20 Plus nab-Paclitaxel/Gemcitabine (PAG) vs AG in Patients with Untreated, Metastatic Pancreatic Ductal Adenocarcinoma 
  1/1/2017
• HALO 301 trial launch in Europe, Australia, Brazil 
  Barcelona, 2017; Sydney, 2017; Rio de Janeiro, 2017 - 1/1/2017
• Round Table Discussion on Biliary Tract Cancer 
  1/25/2017
• Join now to see all

Other

• Case Study Suggests Regorafenib Remains Effective Beyond 
  Seery T, OncLive
  1/5./2016
• Optimizing Care in Metastatic Colorectal Cancer 
  Seery T, OncLive
  1/25/2016